MAFLD or MASLD: Which better represents the prognosis of the steatotic liver population: Letter to the editor on “Evolutionary changes in metabolic dysfunction-associated steatotic liver disease and risk of hepatocellular carcinoma: A nationwide cohort study”
- Affiliations
-
- 1Department of Endocrinology, Shandong Provincial Hospital, Shandong University, Jinan, Shandong, China
- 2Key Laboratory of Endocrine Glucose & Lipids Metabolism and Brain Aging, Ministry of Education, Shandong First Medical University, Jinan, Shandong, China
- 3Key Laboratory of Epidemiology of Major Diseases (Peking University), Ministry of Education, Haidian District, Beijing, China
- 4Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Haidian District, Beijing, China
- 5Department of Endocrinology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China
- 6Department of Endocrinology, Central Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China